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Backgrounds & Aims 
 
Efficient recovery of biologically safe and 
undifferentiated hESCs is a major challenge after cryobanking, 
especially when their use for human therapy is foreseen. One 
drawback of actual cryopreservation protocols is the 
unavoidable direct contact of the cells with liquid nitrogen 
(LN2), due to cooling-induced vacuum. Therefore cells can be 
exposed to heavy metals, bacteria, viruses or fungi during 
cooling and storage. We describe a novel cryopreservation 
method based on aseptic vitrification1 (no direct contact with 
LN2) using only chemically defined materials and media, and 
amenable to automation.  
1: Vitrification is a cryopreservation method based on the conversion of a liquid 
into a glass-like state by an infinite enhancement of its viscosity and  without 
formation of ice crystals. 
 
Experimental Design 
 
 
Results (1) 
Definition of an efficient vitrification protocol fitting to the 
constraints, and not affecting hESCs biology : 
 
 
 
 
 
  
Future 
 
Procedures and media for efficient, biochemically defined, 
aseptic and automatable vitrification have been set up, but can 
still be enhanced. 
 
The whole procedure should be tested by partners on various 
hES cell lines. 
 
Use of marine polysaccharides is still to be evaluated as 
substitutes for cryoprotectants or additives as vitrification 
helpers. 
Discussion 
Aseptic vitrification of RCM1 hESCs is now possible in completely 
defined media. Because straws are directly immersed in LN2, this 
method does not require any specific and expensive material. To limit 
cell manipulations, our protocol implies stepwise addition and dilution 
of cryoprotectants before cooling and after warming, respectively. 
 
Vitrified RCM1 cells maintained their stem state after cooling & 
warming. 
Cell number reduction after vitrification can be explained by the 
conditions allowing aseptic and chemically defined conditions in the 
process of cryopreservation. 
 
Some marine polysaccharides have a positive effect on vitrification by 
reducing ice crystal formation. 
Test of polysaccharides extracted from marine microorganisms 
as viscosity enhancers (=vitrification helper) 
 
Replacement of undefined  by chemically defined compounds 
in the vitrification medium: 
hESC line used: RCM1 (Roslin Cells) 
medium used: mTeSR1®  from  StemCell Technologies® 
Adaptation of procedures and materials to address 
requirements for automation and aseptic vitrification. 
Comparison between conventional slow freezing (SF) (non 
aseptic) in cryotubes and vitrification (V) in sealed straws. 
morphometric studies, karyotyping, IF, teratomas 
A 
B 
HE staining indicates that differenciated elements of 
the 3 germ layers are found in the teratoma 
obtained after s.c. injection of vitrified RCM1 cells 
into dorsal flanks of NSG mice : neuroectoderm (a), 
endodermal epithelium (b), glandular epithelium 
(c), smooth muscle (mesoderm) (d) (x20). 
a 
d 
c b 
Colonies of RCM1 on Matrigel® shown in Hoffman modulation 
contrast 7 days post-thawing after SF (a) or V (b) (x100). 
a b 
Cell growth post-warming 
after cryopreservation of 
1/2 or 1/4 of a well of  a 6-
well plate  respectively  
Aseptic vitrification in 
sealed straw is in 
accordance with EC 
and FDA directives on 
cell and tissue storage: 
requiring that cells are 
protected from any 
possible contamination 
during cooling and 
storage. 
 
A 
    Selection of two marine polysaccharides as candidate cryoprotectants B
Markers of undifferenciated status 
are still expressed after V. 
OCT4 SOX2 
SSEA4 TRA1-81 
A 
Post-warming morphometric analysis indicate that cell morphology is not 
affected by both cryopreservation methods. Even if cell number is 
affected  by V, growth curves evolue parallely. 
Vitrified RCM1 cells present a  
normal 46 XX karyotype . 
